Allergy Therapeutics has announced the appointment of Dr Tunde Otulana as Non-Executive Director, effective from today. We consider the appointment of Dr Otulana as a meaningful addition to the Allergy Board. Alongside significant industry experience, Dr Otulana also spent over six years working at the US FDA as a Medical Officer and Medical Team Leader in the Division of PulmonaryAllergy Drug Products. On this basis, we consider his experience particularly pertinent given Allergy Therapeutic ....